This impact is seen as reduced cell proliferation rates of AMPKα1-S347A mutant cells (figure 2d) and in two genetically diverse colorectal cancer cells lines HCT116 and HT29 when basal AMPK activities were elevated by chemical induction along with metformin exposure (figure 4a,e). This evidence concerns the gene PRKAA2 and colorectal cancer.